# Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol

> **NCT02078570** · — · UNKNOWN · sponsor: **Provista Diagnostics, Inc** · enrollment: 500 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02078570
- **Lead sponsor:** Provista Diagnostics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2017-07
- **Final completion:** —
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2016-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02078570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02078570, "Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02078570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*